Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 West Receives 510(k) Clearance for NovaGuard SA | Contract Pharma
Breaking News

West Receives 510(k) Clearance for NovaGuard SA

Prefillable syringe safety system designed to reduce risk of needlestick injury

West Pharmaceutical Services’ NovaGuard SA (Staked-needle Automatic) safety system has received 510(k) clearance from the FDA. The NovaGuard SA safety system is designed to help reduce the risk of needlestick injuries by shielding the exposed needle of a prefilled syringe after use.
  
“With increased global emphasis on preventing the spread of bloodborne infectious diseases, there is a need to develop and implement safer systems and practices in healthcare facilities worldwide. This includes adopting devices that can help reduce the risk of infection caused by needlestick,” said Graham Reynolds, vice president, marketing and innovation, West Pharmaceutical Services. “West has deep expertise in needlestick prevention and a portfolio of offerings that enable safe and effective drug administration. It’s our hope that the NovaGuard SA safety system is used as a cost-effective solution to help improve needle safety.”
  
The company has increased its manufacturing capacity at its facility in France, where more than 1.5 billion similar safety systems have already been produced. The NovaGuard SA safety system could be available for all geographic markets and commercial supply. Currently, the NovaGuard SA safety system is commercialized with one marketed drug outside of the U.S., and is being evaluated by multiple West pharmaceutical partners.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters